• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biondvax Pharmaceuticals Ltd

+ Add to Watchlist

BNDX:IT

69.10 ILs 0.90 1.29%

As of 05:40:05 ET on 01/25/2015.

Snapshot for Biondvax Pharmaceuticals Ltd (BNDX)

Open: 70.00 Day's Range: 69.10 - 72.00 Volume: 63,700
Previous Close: 70.00 52wk Range: 58.30 - 85.00 1-Yr Rtn: -0.58%

Stock Chart for BNDX

No chart data available.
  • BNDX:IT 69.70
  • 1D
  • 1M
  • 1Y
70.00
Interactive BNDX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BNDX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 37.52
Shares Outstanding (M) 54.30
30 Day Average Volume 83,575
Price/Book (mrq) 2.0493
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BNDX

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BNDX

Biondvax Pharmaceuticals Limited is a pharmaceutical company that develops intra-nasal flu vaccines.

Ron BabecoffPresident/CEOUri Ben OrChief Financial Officer
Tammar Ben YedidyaChief Scientific OfficerShimon HassinChief Operating Officer
More Company Profile & Key Executives for BNDX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil